Liz Cormier-May (co-founder of IV Bioholdings, CEO of Mammogen and CEO of Dragonfly Data Ventures) cares so much about women’s health and the planet she’ll leave for her kids, that she doesn’t care about making people uncomfortable or challenging the ways things have always been done.
In this in-depth conversation you get to feel Liz’s passion for challenging the business model for how drug development and care is done. She helps us bridge the divide that often exists between patients and their care and how a life science company can creatively achieve their expected bottom-line results while meeting patients’ needs.
Some highlights of our conversation include:
1:56 – Who is Liz Cormier-May?
4:21 – What is Dragonfly Data Ventures?
7:04 – Liz’s Why
10:11 – The Fuel to her fire
13:18 – Relook at what we invest in
16:47 – The Life Science business model needs to change
19:39 – We Need to Have Courageous Conversations
22:06 – Creatively Achieving the Bottom-Line
24:24 – Building a Bridge Between Innovation and Patients
26:08 – Treating the Patient as a Consumer
29:36 – Care Access for all
33:45 – Care so much that you don’t care
39:41 – Advice to my younger self
To connect with Liz on LinkedIn: https://www.linkedin.com/in/elizabeth-cormier-may-b02a2272/
To learn more about IV Bioholdings: https://www.ivbh.studio/
To learn more about Mammogen: https://www.mammogen.bio/
To learn more about Dragonfly Data Ventures: https://www.ondragonfly.com/